A detailed history of Deutsche Bank Ag\ transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 86,304 shares of ANIK stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86,304
Previous 82,618 4.46%
Holding current value
$1.34 Million
Previous $2.09 Million 1.86%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$24.25 - $28.75 $89,385 - $105,972
3,686 Added 4.46%
86,304 $2.13 Million
Q2 2024

Aug 14, 2024

SELL
$24.57 - $28.47 $5,110 - $5,921
-208 Reduced 0.25%
82,618 $2.09 Million
Q1 2024

May 15, 2024

BUY
$21.95 - $26.42 $16,901 - $20,343
770 Added 0.94%
82,826 $2.1 Million
Q4 2023

Feb 14, 2024

BUY
$18.47 - $23.3 $1.37 Million - $1.73 Million
74,139 Added 936.45%
82,056 $1.86 Million
Q3 2023

Nov 09, 2023

SELL
$16.98 - $26.1 $1.24 Million - $1.91 Million
-73,025 Reduced 90.22%
7,917 $147,000
Q2 2023

Aug 14, 2023

BUY
$25.16 - $28.86 $1.14 Million - $1.3 Million
45,148 Added 126.13%
80,942 $2.1 Million
Q1 2023

May 15, 2023

BUY
$25.91 - $32.1 $75,838 - $93,956
2,927 Added 8.91%
35,794 $1.03 Million
Q4 2022

Feb 13, 2023

BUY
$23.85 - $31.91 $3,005 - $4,020
126 Added 0.38%
32,867 $972,000
Q3 2022

Nov 14, 2022

SELL
$21.74 - $24.68 $18,544 - $21,052
-853 Reduced 2.54%
32,741 $780,000
Q2 2022

Aug 11, 2022

SELL
$20.4 - $25.53 $19,584 - $24,508
-960 Reduced 2.78%
33,594 $750,000
Q1 2022

May 13, 2022

SELL
$24.7 - $36.54 $23,218 - $34,347
-940 Reduced 2.65%
34,554 $868,000
Q4 2021

Feb 11, 2022

SELL
$35.83 - $45.03 $4,765 - $5,988
-133 Reduced 0.37%
35,494 $1.27 Million
Q3 2021

Nov 04, 2021

BUY
$38.75 - $44.47 $9,183 - $10,539
237 Added 0.67%
35,627 $1.52 Million
Q2 2021

Aug 11, 2021

BUY
$39.42 - $48.08 $742,318 - $905,394
18,831 Added 113.72%
35,390 $1.53 Million
Q1 2021

May 13, 2021

BUY
$32.49 - $45.96 $216,448 - $306,185
6,662 Added 67.31%
16,559 $675,000
Q4 2020

Feb 16, 2021

SELL
$32.59 - $45.26 $103,147 - $143,247
-3,165 Reduced 24.23%
9,897 $448,000
Q3 2020

Nov 12, 2020

SELL
$32.56 - $38.57 $2.79 Million - $3.3 Million
-85,632 Reduced 86.77%
13,062 $462,000
Q2 2020

Aug 13, 2020

SELL
$27.83 - $37.73 $151,144 - $204,911
-5,431 Reduced 5.22%
98,694 $3.72 Million
Q1 2020

May 14, 2020

SELL
$22.38 - $54.06 $400,042 - $966,322
-17,875 Reduced 14.65%
104,125 $3.01 Million
Q4 2019

Feb 14, 2020

BUY
$51.85 - $73.36 $5.8 Million - $8.2 Million
111,804 Added 1096.55%
122,000 $6.32 Million
Q3 2019

Nov 14, 2019

SELL
$40.05 - $57.47 $1.19 Million - $1.71 Million
-29,683 Reduced 74.43%
10,196 $558,000
Q2 2019

Aug 14, 2019

SELL
$30.3 - $41.14 $2.29 Million - $3.11 Million
-75,687 Reduced 65.49%
39,879 $1.62 Million
Q1 2019

May 15, 2019

BUY
$29.37 - $40.49 $396,994 - $547,303
13,517 Added 13.25%
115,566 $3.49 Million
Q4 2018

Feb 14, 2019

SELL
$30.16 - $43.0 $5.79 Million - $8.26 Million
-192,056 Reduced 65.3%
102,049 $3.43 Million
Q3 2018

Dec 21, 2021

BUY
$32.83 - $42.51 $2.39 Million - $3.09 Million
72,721 Added 32.85%
294,105 $12.4 Million
Q3 2018

Nov 14, 2018

SELL
$32.83 - $42.51 $4.92 Million - $6.37 Million
-149,803 Reduced 40.36%
221,384 $9.34 Million
Q2 2018

Apr 21, 2020

BUY
$28.77 - $48.27 $2.66 Million - $4.47 Million
92,583 Added 33.23%
371,187 $11.9 Million
Q2 2018

Aug 14, 2018

BUY
$28.77 - $48.27 $4.12 Million - $6.91 Million
143,220 Added 105.79%
278,604 $8.91 Million
Q1 2018

Oct 18, 2019

BUY
$49.22 - $68.43 $1.74 Million - $2.42 Million
35,357 Added 35.35%
135,384 $6.73 Million
Q1 2018

May 15, 2018

BUY
$49.22 - $68.43 $464,784 - $646,184
9,443 Added 10.42%
100,027 $4.97 Million
Q4 2017

Feb 14, 2018

BUY
$52.14 - $59.94 $1.14 Million - $1.31 Million
21,906 Added 31.9%
90,584 $4.88 Million
Q3 2017

Nov 14, 2017

BUY
$51.16 - $58.21 $3.51 Million - $4 Million
68,678
68,678 $3.98 Million

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $227M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.